Intraocular lymphoma

Current Opinion in Ophthalmology

Volumn 13, Issue 6, 2002, Pages 411-418

  Chan, Chi Chao ^a   Buggage, Ronald R ^a   Nussenblatt, Robert B ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 10; INTERLEUKIN 6; METHOTREXATE; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CEREBROSPINAL FLUID EXAMINATION; EYE TUMOR; FLUORESCENCE ANGIOGRAPHY; GENE REARRANGEMENT; HUMAN; LUMBAR PUNCTURE; LYMPHOMA; NEUROTOXICITY; OPHTHALMOSCOPY; PRIMARY INTRAOCULAR LYMPHOMA; PRIORITY JOURNAL; REVIEW; UVEA TUMOR; UVEITIS; VISUAL IMPAIRMENT; VITRECTOMY;

EYE NEOPLASMS; HUMANS; INCIDENCE; LYMPHOMA; UNITED STATES;

EID: 0036892914     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200212000-00012     Document Type: Review

References (88)

1. Qualman SL, Mendelsohn G, Mann RB, et al: Intraocular lymphomas: natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 1983, 52:878-886.
2. Currey TA, Deutsch AR: Reticulum cell sarcoma of the urea. Southern Med J 1965, 58:919.
3. Barr CC, Green WR, Payne JW, et al: Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literature. Surv Ophthalmol 1975, 19:224-239.
4. Kaplan HJ, Meredith TA, Aaberg TM, et al: Reclassification of intraocular reticulum cell sarcoma (histiocytic lymphoma). Immunologic characterization of vitreous cells. Arch Ophthalmol 1980, 98:707-710.
5. Freeman LN, Schachat AP, Knox DL, et al: Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987, 94:1631-1639.
6. Bataille B, Delwail V, Menet E, et al: Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000, 92:261-266.
7. Paulus W: Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol 1999, 43:203-208.
8. Buggage RR, Chan CC, Nussenblatt RB: Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol 2001, 13:137-142.
9. Tuaillon N, Chan CC: Molecular analysis of primary central nervous system and primary intraocular lymphoma. Curr Mol Med 2001, 1:259-272.
10. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1999. CA Cancer J Clin 1999, 49:8-31, 31.
11. DeAngelis LM: Brain tumors. N Engl J Med 2001, 344:114-123.
12. Corn BW, Marcus SM, Topham A, et al: Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000 Cancer 1997, 79:2409-2413.
13. Schabet M: Epidemiology of primary CNS lymphoma. J Neurooncol 1999, 43:199-201.
14. Eby NL, Grufferman S, Flannelly CM, et al: Increasing incidence of primary brain lymphoma in the US. Cancer 1988, 62:2461-2465.
15. Thomas JO: Acquired immunodeficiency syndrome-associated cancers in sub-Saharan Africa. Semin Oncol 2001, 28:198-206.
16. Nasir S, DeAngelis LM: Update on the management of primary CNS lymphoma. Oncology (Huntingt) 2000, 14:228-234; discussion 237-242, 244.
17. Miller DC, Hochberg FH, Harris NL, et al: Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 1994, 74:1383-1397.
18. Herrlinger U, Schabet M, Bitzer M, et al: Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol 1999, 43:219-226.
19. Cassoux N, Merle-Beral H, Leblond V, et al: Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 2000, 8:243-250.
20. van der Sanden GA, Schouten LJ, van Dijck JA, et al: Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer 2002, 94:1548-1556.
21. Whitcup SM, de Smet MD, Rubin BI, et al: Intraocular lymphoma: clinical and histopathologic diagnosis. Ophthalmology 1993, 100:1399-1406.
22. Peterson K, Gordon KB, Heinemann MH, et al: The clinical spectrum of ocular lymphoma. Cancer 1993, 72:843-849.
23. Akpek EK, Ahmed I, Hochberg FH, et al: Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999, 106:1805-1810.
24. Rothova A, Ooijman F, Kerkhoff F, et al: Uveitis masquerade syndromes. Ophthalmology 2001, 108:386-399.
25. Zamiri P, Boyd S, Lightman S: Uveitis in the elderly-is it easy to identify the masquerade? Br J Ophthalmol 1997, 81:827-831.
26. Read RW, Zamir E, Rao NA: Neoplastic masquerade syndromes. Surv Ophthalmol 2002, 47:81-124.
27. Velez G, de Smet MD, Whitcup SM, et al: Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol 2000, 44:518-526.
28. Matsuo T, Yamaoka A, Shiraga F, et al: Two types of initial ocular manifestations in intraocular-central nervous system lymphoma. Retina 1998, 18:301-307.
29. Shah GK, Kleiner RC, Augsburger JJ, et al: Primary intraocular lymphoma seen with transient white fundus lesions simulating the multiple evanescent white dot syndrome. Arch Ophthalmol 2001, 119:617-620.
30. Merchant A, Foster CS: Primary intraocular lymphoma. Int Ophthalmol Clin 1997, 37:101-115.
31. Ridley ME, McDonald HR, Sternberg P, Jr., et al: Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology 1992, 99:1153-1160; discussion 1160-1151.
32. Levy-Clarke GA, Byrnes GA, Buggage RR, et al: Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. Retina 2001, 21:281-284.
33. Matsuo K, Nakatuka K, Matsuura T, et al: Primary intraocular lymphoma mimicking late postoperative endophthalmitis. Ophthalmologica 1995, 209:331-335.
34. Dean JM, Novak MA, Chan CC, et al: Tumor detachments of the retinal pigment epithelium in ocular/central nervous system lymphoma. Retina 1996, 16:47-56.
35. Velez G, Chan CC, Csaky KG: Fluorescein angiographic findings in primary intraocular lymphoma. Retina 2002, 22:37-43.
36. Augustein WG, Buggage RR, Smith JA, et al: Fluorescein angiogram interpretation in the diagnosis of primary intraocular lymphoma [ARVO abstract]. Invest Ophthalmol vis Sci 2001, 42:S462.
37. Plotkin SR, Batchelor TT: Primary nervous-system lymphoma. Lancet Oncol 2001, 2:354-365.
38. Davis JW, Moriarty RP, Schlossberg SM, et al: Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor. Urology 2001, 57:555.
39. Herrlinger U: Primary CNS lymphoma: findings outside the brain. J Neurooncol 1999, 43:227-230.
40. Ciricillo SF, Rosenblum ML: Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1990, 73:720-724.
41. DeAngelis LM: Primary central nervous system lymphoma. Curr Opin Neurol 1999, 12:687-691.
42. Davis JL, Solomon D, Nussenblatt RB, et al: Immunocytochemical staining of vitreous cells: indications, techniques, and results. Ophthalmology 1992, 99:250-256.
43. Whitcup SM, Chan CC, Buggage RR, et al: Improving the diagnostic yield of vitrectomy for intraocular lymphoma [letter; comment]. Arch Ophthalmol 2000, 118:446.
44. Wilson DJ, Braziel R, Rosenbaum JT: Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens. Arch Ophthalmol 1992, 110:1455-1458.
45. Davis JL, Viciana AL, Ruiz P: Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 1997, 124:362-372.
46. Blumenkranz MS, Ward T, Murphy S, et al: Applications and limitations of vitreoretinal biopsy techniques in intraocular large cell lymphoma. Retina 1992, 12:S64-70.
47. Brown SM, Jampol LM, Cantrill HL: Intraocular lymphoma presenting as retinal vasculitis. Surv Ophthalmol 1994, 39:133-140.
48. Kirmani MH, Thomas EL, Rao NA, Laborde RP: Intraocular reticulum cell sarcoma: diagnosis by choroidal biopsy. Br J Ophthalmol 1987, 71:748-752.
49. Lopez JS, Chan CC, Burnier M, et al: Immunohistochemistry findings in primary intraocular lymphoma. Am J Ophthalmol 1991, 112:472-474.
50. Lefebvre A, Candaele C, Verbraeken H, et al: Choroidal biopsy in the diagnosis of a suspect intraocular lesions. Bull Soc Beige Ophtalmol 1995, 255:93-97.
51. Pavan PR, Oteiza EE, Margo CE: Ocular lymphoma diagnosed by internal subretinal pigment epithelium biopsy [letter]. Arch Ophthalmol 1995, 113:1233-1234.
52. Buggage RR, Velez G, Myers-Powell B, et al: Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene rearrangement. Arch Ophthalmol 1999, 117:1239-1242.
53. Shields JA, Shields CL, Ehya H, et al: Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture. Ophthalmology 1993, 100:1677-1684.
54. Fyrat P, Mocan G: Lymphoma presenting as a solitary mass: diagnosis by fine needle aspiration biopsy. Cytopathology 2000, 11:276-278.
55. Trainor KJ, Brisco MJ, Story CJ, et al: Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990, 75:2220-2222.
56. Linke B, Bolz I, Fayyazi A, et al: Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Leukemia 1997, 11:1055-1062.
57. Shen DF, Zhuang Z, LeHoang P, et al: Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 1998, 105:1664-1669.
58. Gleissner B, Siehl J, Korfel A, et al: CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology 2002, 58:390-396.
59. Lewis SM: The mechanism of V(D)J joining: lessons from molecular, immunologic, and comparative analyses. Adv Immunol 1994, 56:27-150.
60. Chan CC, Shen D, Nussenblatt RB, et al: Detection of molecular changes in primary intraocular lymphoma by microdissection and polymerase chain reaction [letter]. Diagn Mol Pathol 1998, 7:63-64.
61. White VA, Gascoyne RD, Paton KE: Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol 1999, 117:761-765.
62. Chan CC, Shen DF, Whitcup SM, et al. Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphoma. Blood 1999, 93:2749-2751.
63. Chan CC, Shen DF: Newer methodologies in immunohistochemistry and diagnosis. In Uveitis update. Edited by BenEzra D: Karger; 1999:1-13. Behrens-Baumann W (Series Editor): Dev Ophthalmol, vol 31.
64. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haematopoietic cell surviral and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-444.
65. Jacobson JO, Wilkes BM, Kwaiatkowski DJ, et al: bcl-2 rearrangements in de novo diffuse large cell lymphoma: association with distinctive clinical features. Cancer 1993, 72:231-236.
66. Jellinger KA, Paulus W: Primary central nervous system lymphomas-new pathologic developments. J Neurooncol 1995, 24:33-36.
67. Monni O, Franssila K, Joensuu H, et al: BCL2 overexpression in diffuse large B-cell lymphoma. Leuk Lymphoma 1999, 34:45-52.
68. Banchereau J, Briere F, Liu YJ, et al: Molecular control of B lymphocyte growth and differentiation. Stem Cells (Dayt) 1994, 12:278-288.
69. Chan CC, Whitcup SM, Solomon D, et al: Interleukin-10 in the vitreous of primary intraocular lymphoma. Am J Ophthalmol 1995, 120:671-673.
70. Whitcup SM, Stark-Vancs V, Wittes RE, et al: Association of interleukin-10 in the vitreous and cerebral spinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 1997, 115:1157-1160.
71. Buggage RR, Whitcup SM, Nussenblatt RB, et al: Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis [letter]. Invest Ophthalmol Vis Sci 1999, 40:2462-2463.
72. Velez G, Buggage R: Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 2001, 108:427-428.
73. Cassoux N, Merle-Beral H, Lehoang P, et al: Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 2001, 108:426-427.
74. Wolf LA, Reed GF, Buggage RR, et al: Levels of IL-10 and IL-6 in the vitreous are helpfyl for differential diagnosis of primary intraocular lymphoma and ocular inflammation. ARVO Abstract 2002:2221.
75. Akpek EK, Maca SM, Christen WG, et al: Elevated vitreous interleukin-10 level is not diagnostic of intraocular- central nervous system lymphoma. Ophthalmology 1999, 106:2291-2295.
76. O'Neill BP, Wang CH, O'Fallon JR, et al: Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52. Int J Radiat Oncol Biol Phys 1999, 43:559-563.
77. Schultz C, Scott C, Sherman W, et al: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1996, 14:556-564.
78. DeAngelis LM: Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 1999, 43:249-257.
79. Hiraga S, Arita N, Ohnishi T, et al: Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 1999, 91:221-230.
80. Abrey LE, DeAngelis LM, Yahalom J: Long-term survival in primary CNS lymphoma. J Clin Oncol 1998, 16:859-863.
81. Blay JY, Ongolo-Zogo P, Sebban C, et al: Primary cerebral lymphomas: unsolved issues regarding first-line treatment, follow-up, late neurologic toxicity and treatment of relapses. The FNCLCC. French Federation Nationale des Centers de Lutte contre le Cancer. Ann Oncol 2000, 11:39-44.
82. Velez G, Yuan P, Sung C, et al: Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol 2001, 119:1518-1524.
83. de Smet MD, Vancs VS, Kohler D, et al: Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 1999, 83:448-451.
84. Fishburne BC, Wilson DJ, Rosenbaum JT, et al: Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997, 115:1152-1156.
85. Henson JW, Yang J, Batchelor T: Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol 1999, 17:1329.
86. Soussain C, Suzan F, Hoang-Xuan K, et al: Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001, 19:742-749.
87. Morinelli EN, Dugel PU, Riffenburgh R, et al: Infectious multifocal choroiditis in patients with acquired immune deficiency syndrome. Ophthalmology 1993, 100:1014-1021.
88. Rivero ME, Kupperman BD, Wiley CA, et al: Acquired immunodeficiency syndrome-related intraocular B-cell lymphoma. Arch Ophthalmol 1999, 117:616-622.